We describe an automated colorimetric method for determination of uric acid in serum or urine by use of an AutoAnalyzer II or SMA 12/60 (Technicon Corp.). The method depends on reduction of a ferric-phenanthrolirle complex by uric acid under acidic conditions to a ferrous-phenanthroline complex, which absorbs at 505 nm. Advantages of this method over other methods now in use are that color and concentration are linearly related (to 20 mg/100 ml); aqueous reagents are easily prepared, stable, and inexpensive; and interference from ascorbic acid has been eliminated by use of an alkaline copper-containing diluent. The analysis is also free of interference from glucose, creatinine, glutathione, saucylates and hemoglobin. Correlation with results of the Technicon phosphotungstic acid reduction method is excellent (r = .996). Correlation with results of an automated uricase method is satisfactory (r = .979). Recovery of uric acid was 101% over a wide concentration range.
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For over a decade, uric acid has been determined in the clinical laboratory by use of the AutoAnalyzer (1), and more recently of the SMA 12/60 (2), by various modifications of the phosphotungstic acid reduction method. Limitations of this method have been described (3) . These are generally associated with the nonlinear relation between color and concentration above 10 mg/100 ml and interference by other reducing agents such as ascorbic acid. In addition, phosphotungstic acid is time consuming to prepare and the use of sodium tungstate as the alkali with the SMA 12/60 is expensive. Methods in which uricase is used have become more popular, mainly because of their specificity. However, manual methods are time consuming and require larger volumes of serum, and the uricase reagent for both manual and automated procedures is relatively expensive, and the enzyme is easily poi- Their system made use of a cupric sulfate-neocuproine indicator in which the cupric ion is reduced by uric acid in a weakly acid medium. The system was automated (5) and though linearity was improved, there was interference from ascorbic acid, glucose, and sulfhydryl compounds if they were present in high concentrations.The indicator reagent has to be prepared freshly each day, contains an organic solvent, and is expensive.
Recently Morin and Prox (6) introduced a manual method in which ferric chloride and 1,10-phenanthroline are used as a reduction-oxidation indicator in an acid medium at pH 5.5. The procedure was linear over a wide range and was not affected by the reducing substances commonly encountered in routine analysis, except for ascorbic acid, which interfered above 3 mg/100 ml. This paper describes the automation of this method, with modifications that increase sensitivity and linearity and eliminate interference from ascorbic acid. The reagents are entirely aqueous, simple to prepare, and stable.
Materials and Methods

Reagents and Standards
Glycine buffer, 0.1 mol/liter, pH 9.6. Dissolve 7.5 g of glycine in 800 ml of distilled water. Add 1.5 g of sodium hydroxide and dissolve. Add 9 g of sodium chloride and 150 mg of copper sulfate pentahydrate and dissolve. Dilute to 1 liter, check the pH, and adjust it if necessary to 9.6. Add 1 ml of Triton X-100 ( cluding a 20 mg/lOO ml standard. The 20 mg/100 ml standard reaches 95% of the 20 mg/100 ml steady state at a sampling rate of 60/h. Interaction characteristics are demonstrated by the 15 mg/100 ml standard followed by a 4 mg/100 ml standard. Carryover is about 5%. The 20 mg/100 ml standard is included only to demonstrate the linearity of the system and is not normally used in routine analysis. Also shown is a typical run of a pool and unknown serum samples. Figure 4 , a graphed representation of the standard curve in Figure 3 , shows the linearity of the reaction to 20 mg/lO0 ml. Figure 5 demonstrates the linearity of the method on the SMA 12/60 with use of aqueous standards.
Recovery for the procedure was verified by use of a serum pool to which was added various amounts of uric acid standard. Table 1 lists these results. The mean recovery is 101% of the calculated theoretical value.
The precision of the method with the AutoAnalyzer II and the SMA 12/60 was measured with respect to both within-run and day-to-day variation,by using a normal serum pool, which had been aliquoted and frozen at -20 #{176}C. Each day, fivesuch aliquots were distributed randomly throughout the run on each system. Within-run_variability was determined by the formula s = vd2/2n
and day-to-day variation was determined according to the formula s = /(x --1) (7). Table 2 summarizes the data for a 12-day period.
The proposed method was compared with the unmodified Technicon N-13 phosphotungstic reduction
Procedure
Blood samples were collected in red-stoppered "Vacutainer" tubes (Becton-Dickinson, Rutherford, N. J. 07070), which contain no anticoagulant. The samples were allowed to clot for 30 mm, centrifuged, and the serum was removed and used for analysis.
The reagent baseline on the single-channel AutoAnalyzer is adjusted to 2 chart divisions on the recorder with all reagents being pumped through their respective lines, water through the sample line and the damping control in position 1. The standard calibration control on the colorimeter is set at about 5 turns to give a full-scale recording of the 15 mg/l00 ml standard.
The aqueous uric acid working standards are placed on the sample tray in ascending sequence followed by the serum samples, controls, etc., and aspirated at a rate of 60/h, with a 2:1 cam.
The operation of the SMA 12/60 is unchanged from the standard operating procedure. The baseline is set at "zero" while water is being aspirated through the sample line. The standard calibration control is then set to the serum reference standard value. Figure 3 shows a typical recording on the AutoAnalyzer II system demonstrating a steady state (continuous aspiration)
Results
followed by a standard curve in- Several individual samples showed marked differences that may be attributed to unknown reducing substances other than those examined.
The applicability of the method to determine uric acid in urine was studied by comparison to the phosphotungstic reduction method. Figure 8 depicts the correlation of the two methods (r = 0.995) and indicates a slight proportional error (9). 
Optimum Conditions for the Reaction
Morin and Prox (6) reported a 0.1 mol/liter maleic acid buffer at pH 5.5 as the medium for the reduction of the ferric-phenanthroline complex. We observed that when a 0.1 mol/liter acetate buffer was used,
there was a plateau between pH 5.4 and 4.8 and then a sharp rise in sensitivity, which peaked at pH 3.5 ( Figure 9 ). We chose a pH of 3.6, to achieve a slightly increased buffering capacity. It was also observed that use of a 0.1 mol/literglycine buffer gave almost identical results; it could be used in place of the acetate buffer.
Varying the concentration of the acetate buffer between 0.1 and 0.4 mol/liter lowered the sensitivity of the reaction (Figure 10 ). However, to maintain a proper reaction pH of 3.6 while the sample was being dialyzed against a diluent stream of 0.1 mol/liter glycine (pH 9.6), we chose a concentration of 0.3 mol/ liter.
It is known that 1 mole of iron complexes with 3 moles of 1,10-phenanthroline or phenanthroline-like compounds such as bathophenanthroline (10) . Based on this relationship, a single stable reduction-oxidation indicator system was prepared by combining 2 mmol of ferric ions and 10 mmol of 1,10-phenanthroline in distilled water containing 10 mmol of hydrochloric acid to solubilize the 1,10-phenanthroline by we added citric acid to the reaction mixture just prior to its entering the flow cell to chelate the ferric hydroxide and keep it in solution. Varying the citric acid concentration from 0.01 to 0.15 mol/liter showed no effect on the sensitivity of the reaction. We chose a concentration of 0.1 mol/liter to ensure complete chelation of ferric hydroxide.
Effects of Interfering Substances
Because this method depends on the reducing properties of uric acid, we expected and confirmed that ascorbic acid would interfere. Adding ascorbic acid to serum to give a concentration range of 1 to 10 mg/100 ml showed that 1 mg of ascorbic acid per 100 ml was equivalent to 0.7 mg of uric acid per 100 ml. For the phosphotungstic acid reduction method, 1 mg of ascorbic acid per 100 ml was equivalent to 0.3 mg of uric acid per 100 ml.
In attempting to eliminate the ascorbic acid interference, we added a number of organic compounds (2,6-dichlorophenolindophenol, j9-napthoquinone-4-sulfonate, thionine, and methylene blue) to the diluent stream in an attempt to oxidize ascorbic acid to dehydroascorbic acid. In all cases, ascorbic acid was oxidized but the compounds themselves interfered and produced inconsistent results. Copper ions have been used (11) to catalyze the oxidation of ascorbic acid. Cupric sulfate added to the diluent stream at a concentration of 150 mg/liter was found to oxidize ascorbic acid in an alkaline medium. Using a 0.1 mol/liter glycine buffer and varying the pH, we showed complete oxidation up to 10 mgI 100 ml at a pH of 9.6. Under these conditions no interference on the reaction with uric acid was observed.
Glucose did iot interfere up to 500 mg/i00 ml.
Glucose requires an alkaline medium plus heat to reduce metal ions such as copper and iron.
Creatinine, glutathione, and salicylates did not interfere up to 5 mg/i#{174} ml. Similarly, hemoglobin up to a concentration of 900 mg/i#{174}ml did not interfere.
